Genentech
Gilead opens new research centre bringing together oncology, inflammation and research data science teams
The centre in California supports the company’s $32bn US investment
Genentech’s US manufacturing facility advances with construction milestone
The facility is part of Roche and Genentech’s broader $50bn commitment to US R&D and manufacturing infrastructure
Genentech increases investment to $2bn for US manufacturing site
Roche and Genentech have a current commitment of $50bn for US manufacturing
Genentech reports positive trial results for obesity treatment
The treatment is designed to tackle obesity by reducing appetite and regulating blood sugar
Amgen agrees to lower prescription drug costs in deal with US government
The company has invested $40bn in US R&D and manufacturing in the past seven years
Lilly announces plans for $6bn US manufacture facility
The site is the third of four new US sites that Lilly has announced
AstraZeneca announces $2bn investment in US manufacturing
The new and expanded facilities will support production of rare disease drug treatments
Genentech announces positive clinical results for BTK inhibitor MS treatment
Multiple sclerosis affects more than 2.9 million people globally
AstraZeneca to invest $4.5bn in US manufacturing facility
The investment will further support the company’s growing oncology pipeline
Genentech starts construction on manufacturing facility in North Carolina, US
The $700m project is part of Roche’s $50bn investment in the US
Roche’s Genentech enters $765m autoimmune disease partnership with Repertoire
The collaboration will leverage Repertoire’s immune mapping DECODE platform
Roche’s Genentech granted FDA approval for TNKase in acute ischaemic stroke
TNKase is the first stroke medicine to be approved by the regulator in almost three decades